Servier Acquires Menin Inhibitor BN104 from BioNova

McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here